Edition: United States  
One News Page
“Probably the fastest-access news portal in the world”
> >

Sprint and Samsung Test Massive MIMO Technology in South Korea

Business Wire Tuesday, 20 June 2017
Sprint and Samsung Test Massive MIMO Technology in South KoreaOVERLAND PARK, Kan.--(BUSINESS WIRE)--Sprint and Samsung test Massive MIMO in South Korea in preparation for U.S. deployment.
Share on
Share on
Post on 
Share by

Recent related news

Samsung worker scores victory at South Korea's Supreme Court

SEOUL, South Korea (AP) — Overturning an appeals court's decision, South Korea's Supreme Court says a family of a Samsung worker who died of brain tumor should...
SeattlePI.com - BusinessAlso reported by •Seattle TimesSoftpediaZero Hedge

Apple’s iPhone X Sold Out in Just 2 Minutes in Samsung’s Home Market

Apple’s iPhone X Sold Out in Just 2 Minutes in Samsung’s Home Market
The iPhone X was sold out in the United States in just 10 minutes following a combo of huge demand and low inventory, and now it turns out the same thing...
Softpedia - Technology

You Might Like

Other recent news in Press Releases

Margot Jordan of AST Trust Company (CANADA) Named One of CANADA’s Most Powerful WomenDozens of Games at Big Discounts Are Part of the NINTENDO eShop Cyber Deals
Executive Assistant Course - CPD Accredited (LONDON, United Kingdom - November 27-29, 2017) - Research and MarketsKBRA Assigns AAA Rating with a Stable Outlook on Wisconsin’s Transportation REVENUE Refunding Bonds, 2017 Series 2
KOST 103.5’s The Ellen K Morning Show to Broadcast From CHILDREN’s Hospital Los Angeles on Giving Tuesday to Launch Hospital’s Annual ‘Live L.A. Give L.A.’ CampaignHot Topics Recap: Black Friday/CYBER MONDAY
Gilead Sciences to Present at the NASDAQ 37th Investor Program on Wednesday, December 6Tennant Company to Present its Growth Strategy at the Bank of America Merrill Lynch 2017 Leveraged Finance Conference in Boca Raton, FLORIDA, November 30
BEIJING Capital Grand Breaks Into the 2017 Top 20 List of China's Commercial Property OperatorsPuma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in AUSTRALIA, New Zealand and South East Asia


Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+